TRP Channels in Tumoral Processes Mediated by Oxidative Stress and Inflammation

Florentina Piciu1, Mihaela Balas2, Madalina Andreea Badea2,3

  • 1Department of Anatomy, Animal Physiology and Biophysics (DAFAB), Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, 050095 Bucharest, Romania.

Insights

Reactive oxygen species (ROS) activate transient receptor potential (TRP) channels, influencing cancer cell behavior. Targeting these redox channels offers a promising therapeutic strategy for cancer inhibition.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Transient Receptor Potential (TRP) channels are activated by reactive oxygen species (ROS), acting as redox sensors.
  • Specific TRP channels (TRPC4, TRPC5, TRPV1, TRPV4, TRPA1) are directly sensitive to oxidative stress, while others (TRPC3, TRPM2, TRPM7) are indirectly activated.
  • ROS-mediated TRP channel activation has complex, context-dependent effects on cancer cell proliferation, apoptosis, and migration.

Purpose of the Study:

  • To explore the intricate interplay between oxidative stress, TRP channels, and inflammation in cancer.
  • To review recent data and propose cancer inhibition pathways utilizing TRP protein modulators.
  • To bridge the gap between experimental findings and clinical applications for TRP-targeted cancer therapies.

Main Methods:

  • Literature review of recently published data on TRP channels, oxidative stress, and cancer.
  • Analysis of cellular models and proposed pathways for cancer inhibition.
  • Discussion of the therapeutic potential of TRP channel modulators.

Main Results:

  • TRP channels exhibit diverse roles in cancer progression, either promoting or inhibiting tumorigenesis.
  • Modulation of TRP channels by ROS is influenced by cancer type, microenvironment, and experimental methods.
  • TRP channels represent potential therapeutic targets due to their druggability and modulation by simple compounds.

Conclusions:

  • Targeting TRP channels offers a promising avenue for cancer therapy.
  • Further research integrating experimental and clinical data is needed to translate bench findings to bedside applications.
  • Understanding the redox-channel-inflammation axis is crucial for developing effective cancer treatments.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K